AngioDynamics Inc. reported unaudited consolidated earnings results for the second quarter and six months ended November 30, 2016. For the quarter, the company's net sales were $89,029,000 against $89,234,000 a year ago. Operating income was $15,588,000 against $565,000 a year ago. Income before income taxes was $14,415,000 against loss before income taxes of $565,000 a year ago. Net income was $13,734,000 against net loss of $334,000 a year ago. Earnings per basic and diluted share were $0.37 against loss per share basic and diluted of $0.01 a year ago. Adjusted net income was $6,926,000 against $5,100,000 a year ago. Adjusted diluted earnings per share were $0.19 against $0.14 a year ago. EBITDA was $21,621,000 against $7,643,000 a year ago. Adjusted EBITDA was $16,141,000 against $13,528,000 a year ago. EBITDA per diluted share was $0.58 against $0.21 a year ago. Adjusted EBITDA was $0.43 against $0.37 a year ago. Net cash provided by operating activities was $14,947,000 against $9,579,000 a year ago. Additions to property, plant and equipment was $1,365,000 against $425,000 a year ago. The company generated $13.6 million in free cash flow.

For the six months, the company's net sales were $177,127,000 against $173,037,000 a year ago. Operating income was $19,160,000 against $777,000 a year ago. Income before income taxes was $17,318,000 against loss before income taxes of $1,376,000 a year ago. Net income was $15,034,000 against net loss of $1,109,000 a year ago. Loss per basic and diluted share was $0.03 against earnings per share basic and diluted of $0.05 a year ago. Earnings per basic and diluted share were $0.41 against loss per share basic and diluted of $0.03 a year ago. Adjusted net income was $13,323,000 against $9,042,000 a year ago. Adjusted diluted earnings per share were $0.36 against $0.25 a year ago. EBITDA was $31,236,000 against $14,849,000 a year ago. Adjusted EBITDA was $30,993,000 against $25,122,000 a year ago. EBITDA per diluted share was $0.84 against $0.41 a year ago. Adjusted EBITDA was $0.84 against $0.69 a year ago. Net cash provided by operating activities was $22,387,000 against $14,278,000 a year ago. Additions to property, plant and equipment was $1,846,000 against $1,168,000 a year ago.

The company announced its fiscal year 2017 revenue guidance will remain unchanged, with net sales guidance in the range of $355 million to $360 million. The company is increasing its fiscal year 2017 adjusted EPS guidance from a range of $0.62 to $0.65 to a range of $0.65 to $0.67 and free cash flow guidance from greater than $30 million to greater than $35 million.